Halifax, NS
ImmunoVaccine Technologies Inc. (IVT) is commercializing a proprietary liposome formulation for vaccines, trade named VacciMax. SpayVac, the company's first product, is the only single-dose contraceptive vaccine for controlling fertility in domestic pets and wildlife.
303-1819 Granville St.
Halifax, NS B3J 3R1
CA
303-1819 Granville St.
Halifax, NS B3J 3R1
CA
Legal Name: ImmunoVaccine Technologies Inc.
Number of Employees: 12
CA
VacciMax is a multi-product immune response enhancement platform, capable of delivering a protected non-degraded antigen to the immune system. The ability of VacciMax for three-dimensional antigen recognition combined with a more rapid, greater and multi-year antibody and cell-mediated immune response following a single inoculation is unprecedented in the field of immunology. VacciMax can be used for a wide range of commercial vaccine applications.
The SpayVac contraceptive vaccines are proving successful in a number of mammalian, fish and bird species, with some results showing 90-100% efficacy that is long lasting (up to ten years) from a single administration.
ImmunoVaccine Technologies Inc. is currently involved in a broad spectrum of strategic alliances around the world, including several human vaccine companies, veterinary products companies, governments, universities and non-profit groups.
Title: Chief Operating Officer
Area of Responsibility: Management Executive
Phone: Show phone
541710
Hong Kong, California, Colorado, Connecticut, Florida, Georgia, Massachusetts, New Jersey, Oregon, Pennsylvania, Texas, Washington
Japan, United Kingdom